PTHS Announces CEO Plesha to Speak at Piper Sandler Biopharma Symposium, Xepi/Xeglyze Acquisitions, $175M 2028 Revenue Outlook
Pelthos Therapeutics Inc. · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $26.20
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS